Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Talphera Inc (TLPH)

Talphera Inc (TLPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 51,271
  • Shares Outstanding, K 46,610
  • Annual Sales, $ 0 K
  • Annual Income, $ -13,000 K
  • EBIT $ -13 M
  • EBITDA $ -13 M
  • 60-Month Beta 0.25
  • Price/Sales 1,229.16
  • Price/Cash Flow N/A
  • Price/Book 2.75

Options Overview Details

View History
  • Implied Volatility 525.94% (-27.93%)
  • Historical Volatility 81.78%
  • IV Percentile 63%
  • IV Rank 38.14%
  • IV High 1,215.52% on 04/28/25
  • IV Low 100.85% on 09/05/25
  • Expected Move (DTE 17) 0.2550 (23.83%)
  • Put/Call Vol Ratio 0.41
  • Today's Volume 205
  • Volume Avg (30-Day) 1,188
  • Put/Call OI Ratio 0.85
  • Today's Open Interest 21,095
  • Open Int (30-Day) 22,696
  • Expected Range 0.8150 to 1.3250

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.15
  • Growth Rate Est. (year over year) +666,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0200 +4.90%
on 12/22/25
1.3800 -22.46%
on 12/01/25
-0.2600 (-19.55%)
since 11/28/25
3-Month
0.8580 +24.71%
on 10/03/25
1.5700 -31.85%
on 11/24/25
+0.1600 (+17.58%)
since 09/29/25
52-Week
0.3800 +181.58%
on 07/14/25
1.5700 -31.85%
on 11/24/25
+0.5400 (+101.89%)
since 12/27/24

Most Recent Stories

More News
Talphera: Q3 Earnings Snapshot

Talphera: Q3 Earnings Snapshot

TLPH : 1.0700 (-2.73%)
Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Closed $17 million first tranche financing led by a strategic investment from CorMedix, Inc.

TLPH : 1.0700 (-2.73%)
CRMD : 12.73 (+1.60%)
Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025

SAN MATEO, Calif. , Nov. 5, 2025 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies...

TLPH : 1.0700 (-2.73%)
Talphera Announces the Appointment of Joe Todisco to Board of Directors

SAN MATEO, Calif. , Oct. 21, 2025 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), (Talphera), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies...

TLPH : 1.0700 (-2.73%)
CRMD : 12.73 (+1.60%)
CorMedix Announces Strategic Minority Investment in Talphera

BERKELEY HEIGHTS, N.J., Sept. 08, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (“CorMedix”) (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for...

TLPH : 1.0700 (-2.73%)
CRMD : 12.73 (+1.60%)
Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market

CorMedix is making a strategic investment in Talphera as the lead investor, supported by existing stockholders Nantahala, Rosalind and Rock Springs with several new institutional investors

TLPH : 1.0700 (-2.73%)
CRMD : 12.73 (+1.60%)
Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial

The NEPHRO CRRT pivotal trial has now reached approximately 25% enrollment, driven by the recent acceleration in the recruitment rate from new profile clinical sites

TLPH : 1.0700 (-2.73%)
Talphera: Q2 Earnings Snapshot

Talphera: Q2 Earnings Snapshot

TLPH : 1.0700 (-2.73%)
Talphera Announces Second Quarter 2025 Financial Results and Provides Corporate Update

New sites accelerate registrational study enrollment - 15 patients have been enrolled in the NEPHRO study which remains on track with completion projected by the end of the year

TLPH : 1.0700 (-2.73%)
Talphera to Host Second Quarter Financial Results and Corporate Update Call and Webcast on Thursday, August 14, 2025

SAN MATEO, Calif. , Aug. 7, 2025 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative...

TLPH : 1.0700 (-2.73%)

Business Summary

Talphera Inc. is a specialty pharmaceutical company. It focused on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate consists Niyad(TM). Talphera Inc., formerly known as AcelRx Pharmaceuticals Inc., is based in SAN MATEO,...

See More

Key Turning Points

3rd Resistance Point 1.2163
2nd Resistance Point 1.1751
1st Resistance Point 1.1225
Last Price 1.0700
1st Support Level 1.0287
2nd Support Level 0.9875
3rd Support Level 0.9349

See More

52-Week High 1.5700
Fibonacci 61.8% 1.1154
Last Price 1.0700
Fibonacci 50% 0.9750
Fibonacci 38.2% 0.8346
52-Week Low 0.3800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar